Literature DB >> 3773055

Genetic background affects integration frequency of ecotropic proviral sequences into the mouse germ line.

V L Bautch.   

Abstract

Germ line acquisition of ecotropic proviruses occurs at a high frequency in the progeny of SWR/J-RF/J hybrid mice carrying two genetically linked RF/J ecotropic proviral loci, Emv-16 and Emv-17 (N. A. Jenkins and N. G. Copeland, Cell 43:811-819, 1985). To determine if genetic background affects proviral integration frequency, I analyzed a series of crosses in which the two RF/J proviral loci were transferred onto different provirus-negative background strains. Unlike SWR/J-RF/J hybrid progeny, few CBA/CaJ-RF/J hybrid mice were identified that carried new germ line proviral loci. These results indicate that genetic factors other than the linked RF/J proviral loci contribute to the increased frequency of germ line provirus integration seen in the SWR/J-RF/J hybrids. The frequency of proviral acquisition appeared to increase when females carrying Emv-16, Emv-17, and at least one new proviral locus were further backcrossed, suggesting that integration frequency can be increased by genetic manipulation. The breeding data are consistent with the hypothesis that virus from the mother infects the egg or the early embryo. Analysis of the transmission frequency and cosegregation patterns of new proviral loci indicated that viral integration occurs after the first round of DNA replication and before the germ line is set aside during embryogenesis, with a majority of viral integrations occurring at the two-cell stage of development, and independent viral integrations can occur in the same or in different cells of the embryo.

Entities:  

Mesh:

Year:  1986        PMID: 3773055      PMCID: PMC288943     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  An insertional mutation in a transgenic mouse line results in developmental arrest at day 5 of gestation.

Authors:  W H Mark; K Signorelli; E Lacy
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1985

4.  Fv-1 regulation of lymphoma development and of thymic ecotropic and xenotropic MuLV expression in mice of the AKR/J x RF/J cross.

Authors:  A Mayer; M L Duran-Reynals; F Lilly
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

5.  Genetic factors in the natural history of murine leukemia virus infection: G. H. A. Clowes Memorial Lecture.

Authors:  W P Rowe
Journal:  Cancer Res       Date:  1973-12       Impact factor: 12.701

6.  Reproduction in single-sex chimeras.

Authors:  A McLaren
Journal:  Basic Life Sci       Date:  1978

7.  Distribution of three classes of endogenous type-C RNA viruses among inbred strains of mice.

Authors:  J R Stephension; R K Reynolds; S R Tronick; S A Aaronson
Journal:  Virology       Date:  1975-10       Impact factor: 3.616

8.  A membrane-filter technique for the detection of complementary DNA.

Authors:  D T Denhardt
Journal:  Biochem Biophys Res Commun       Date:  1966-06-13       Impact factor: 3.575

9.  AKR murine leukemia virus genome: frequency of sequences in DNA of high-, low-, and non-virus-yielding mouse strains.

Authors:  D R Lowy; S K Chattopadhyay; N M Teich; W P Rowe; A S Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

10.  Quantitative studies of naturally occurring murine leukemia virus infection of AKR mice.

Authors:  W P Rowe; T Pincus
Journal:  J Exp Med       Date:  1972-02-01       Impact factor: 14.307

View more
  9 in total

1.  Inoculation of newborn SWR/J females with an ecotropic murine leukemia virus can produce transgenic mice.

Authors:  J J Panthier; H Condamine; F Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

Review 2.  Development of retroviral vectors as safe, targeted gene delivery systems.

Authors:  W H Günzburg; B Salmons
Journal:  J Mol Med (Berl)       Date:  1996-04       Impact factor: 4.599

3.  Pattern of expression of ecotropic murine leukemia virus in gonads of inoculated SWR/J mice.

Authors:  J J Panthier; P Gounon; H Condamine; F Jacob
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

4.  Segregation, viral phenotype, and proviral structure of 23 avian leukosis virus inserts in the germ line of chickens.

Authors:  L B Crittenden; D W Salter; M J Federspiel
Journal:  Theor Appl Genet       Date:  1989-04       Impact factor: 5.699

5.  The endogenous ecotropic murine retroviruses Emv-16 and Emv-17 are both capable of producing new proviral insertions in the mouse genome.

Authors:  C Szabo; Y K Kim; W H Mark
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

6.  The polyomavirus early region gene in transgenic mice causes vascular and bone tumors.

Authors:  R Wang; V L Bautch
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

7.  Spontaneous germ line virus infection and retroviral insertional mutagenesis in eighteen transgenic Srev lines of mice.

Authors:  S E Spence; D J Gilbert; D A Swing; N G Copeland; N A Jenkins
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

8.  Studies of the mechanism of spontaneous germline ecotropic provirus acquisition in mice.

Authors:  L F Lock; E Keshet; D J Gilbert; N A Jenkins; N G Copeland
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

9.  Hyperplasia and tumours in lung, breast and other tissues in mice carrying a RAR beta 4-like transgene.

Authors:  J Bérard; L Gaboury; M Landers; Y De Repentigny; B Houle; R Kothary; W E Bradley
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.